SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-19-023939
Filing Date
2019-11-18
Accepted
2019-11-18 17:27:19
Documents
1
Group Members
VIVO CAPITAL LLCVIVO VENTURES FUND VI, L.P.VIVO VENTURES VI AFFILIATES FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A sc13d1119a3eiger_vivo.htm SC 13D/A 102740
  Complete submission text file 0001213900-19-023939.txt   104410
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Subject) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87931 | Film No.: 191228457
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 (650) 688-0818
Vivo Ventures VI, LLC (Filed by) CIK: 0001469547 (see all company filings)

IRS No.: 208829402 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A